AstraZeneca cuts 600 sales jobs in US, Bloomberg News reports
AstraZeneca cuts 600 sales jobs in US, Bloomberg News reports Nov 13 (Reuters) - AstraZeneca AZN.L has cut about 600 jobs from its respiratory and immunology commercial teams in the US as part of its cost savings initiative, Bloomberg News reported on Friday, citing people familiar with the matter.
Reuters could not immediately verify the report.
(Reporting by Unnamalai L in Bengaluru; Editing by Leroy Leo)
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)